| scholarly article | Q13442814 |
| P50 | author | Mohamed A Elrayess | Q59566964 |
| Morana Jaganjac | Q41876125 | ||
| P2093 | author name string | Nayef A Mazloum | |
| Vidya Mohamed-Ali | |||
| Mohammed Alsayrafi | |||
| Moataz Bashah | |||
| Fatima Al-Khelaifi | |||
| Ilhame Diboun | |||
| Houari Abdesselem | |||
| Wael Kafienah | |||
| Shamma Almuraikhy | |||
| P2860 | cites work | Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence | Q24626078 |
| Mechanisms and Metabolic Implications of Regional Differences among Fat Depots | Q27004113 | ||
| Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow | Q28281346 | ||
| Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats | Q28379378 | ||
| Increased oxidative stress in obesity and its impact on metabolic syndrome | Q29012150 | ||
| Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor | Q29547912 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Adipocyte differentiation from the inside out | Q29615690 | ||
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
| Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans | Q29622900 | ||
| Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region | Q33195176 | ||
| Adipocyte turnover: relevance to human adipose tissue morphology | Q33556451 | ||
| Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation | Q33694864 | ||
| Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
| β-Adrenergic Regulation of IL-6 Release from Adipose Tissue:In Vivoandin VitroStudies | Q34104598 | ||
| Fat tissue, aging, and cellular senescence | Q34130783 | ||
| The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity | Q34271384 | ||
| Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils | Q62658841 | ||
| Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis | Q62658906 | ||
| Relationship between degree of obesity and in vivo insulin action in man | Q69885304 | ||
| Surface protein characterization of human adipose tissue-derived stromal cells | Q74559072 | ||
| Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots | Q80596917 | ||
| Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1 | Q34449273 | ||
| Identification and characterization of metabolically benign obesity in humans | Q34807153 | ||
| A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. | Q35061663 | ||
| Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat | Q35130591 | ||
| Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4 | Q37110526 | ||
| Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults | Q37163053 | ||
| RANTES release by human adipose tissue in vivo and evidence for depot-specific differences | Q37216728 | ||
| Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation | Q37236239 | ||
| Inflammation and impaired adipogenesis in hypertrophic obesity in man. | Q37557999 | ||
| The autocrine and paracrine roles of adipokines. | Q37641459 | ||
| Insulin-sensitive obesity in humans - a 'favorable fat' phenotype? | Q37979422 | ||
| A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes | Q38266134 | ||
| Effects of age, sex, and clinical conditions on adipose tissue cellularity in man | Q39946915 | ||
| Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance | Q41299746 | ||
| Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle | Q42135596 | ||
| Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes. | Q42439066 | ||
| Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function | Q42504083 | ||
| Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects | Q42797512 | ||
| Pref-1, a preadipocyte secreted factor that inhibits adipogenesis | Q42833486 | ||
| Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. | Q42834547 | ||
| Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro | Q43982432 | ||
| Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice | Q44631827 | ||
| Differentiation of adipose stem cells | Q45878079 | ||
| The metabolically healthy but obese individual presents a favorable inflammation profile | Q46458620 | ||
| Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. | Q47344563 | ||
| Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study | Q47580330 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P921 | main subject | obesity | Q12174 |
| insulin resistance | Q1053470 | ||
| adipogenesis | Q2824461 | ||
| P304 | page(s) | 2406-2416 | |
| P577 | publication date | 2016-06-24 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance | |
| P478 | volume | 59 |
| Q90055054 | A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses |
| Q101038774 | BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice |
| Q37716083 | Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients |
| Q90678059 | Cytokines and inflammation in adipogenesis: an updated review |
| Q98226258 | Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation |
| Q54108131 | High glucose suppresses the viability and proliferation of HTR‑8/SVneo cells through regulation of the miR‑137/PRKAA1/IL‑6 axis |
| Q49357657 | IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways |
| Q90365735 | Impaired Glucocorticoid Suppression of TGFβ Signaling in Human Omental Adipose Tissues Limits Adipogenesis and May Promote Fibrosis |
| Q90121101 | Metabolically healthy obesity: facts and fantasies |
| Q91810395 | The endocrine function of adipose tissues in health and cardiometabolic disease |
| Q47362763 | The role of exercise-induced myokines in regulating metabolism. |
| Q55428363 | Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals. |
Search more.